Our findings reveal a novel SOX17–Nestin–p16INK4a regulatory pathway that governs pulmonary endothelial cell senescence, which offers new insights into PAH pathobiology and represents a promising therapeutic target for intervention. Here, SOX17 is linked to pulmonary arterial hypertension.